检索结果 - Cali, Anna
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Evidence for Early Defects in Insulin Sensitivity and Secretion Before the Onset of Glucose Dysregulation in Obese Youths: A Longitudinal Study 由 Giannini, Cosimo, Weiss, Ram, Cali, Anna, Bonadonna, Riccardo, Santoro, Nicola, Pierpont, Bridget, Shaw, Melissa, Caprio, Sonia
出版 2012Text -
9
-
10
-
11
A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with... 由 Bolli, Geremia B., Wysham, Carol, Fisher, Miles, Chevalier, Soazig, Cali, Anna M. G., Leroy, Bruno, Riddle, Matthew C.
出版 2018Text -
12
-
13
Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA 由 Mauricio, Dídac, Meneghini, Luigi, Seufert, Jochen, Liao, Laura, Wang, Hongwei, Tong, Liyue, Cali, Anna, Stella, Peter, Carita, Paulo, Khunti, Kamlesh
出版 2017Text -
14
Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-Worl... 由 Gupta, Shaloo, Wang, Hongwei, Skolnik, Neil, Tong, Liyue, Liebert, Ryan M., Lee, Lulu K., Stella, Peter, Cali, Anna, Preblick, Ronald
出版 2018Text -
15
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the... 由 Meneghini, Luigi F., Sullivan, Sean D., Oster, Gerry, Busch, Robert, Cali, Anna M. G., Dauchy, Arnaud, Gill, Jasvinder, Bailey, Timothy S.
出版 2020Text -
16
Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents 由 Cali, Anna M.G., Man, Chiara Dalla, Cobelli, Claudio, Dziura, James, Seyal, Aisha, Shaw, Melissa, Allen, Karin, Chen, Shu, Caprio, Sonia
出版 2009Text -
17
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment 由 Javier Escalada, F., Halimi, Serge, Senior, Peter A., Bonnemaire, Mireille, Cali, Anna M. G., Melas‐Melt, Lydie, Karalliedde, Janaka, Ritzel, Robert A.
出版 2018Text -
18
-
19
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (ED... 由 Roussel, Ronan, d'Emden, Michael C., Fisher, Miles, Ampudia‐Blasco, F. Javier, Stella, Peter, Bizet, Florence, Cali, Anna M. G., Wysham, Carol H.
出版 2017Text -
20
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting 由 Meneghini, Luigi F., Mauricio, Didac, Orsi, Emanuela, Lalic, Nebojsa M., Cali, Anna M.G., Westerbacka, Jukka, Stella, Peter, Candelas, DEA, Christophe, Pilorget, Valerie, Perfetti, Riccardo, Khunti, Kamlesh
出版 2019Text